Gonorrhea Latest Advances

Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae.

Journal: bioRxiv : the preprint server for biology

Published: December 15, 2025

Current European diagnostic and therapeutic guideline in bacterial sexually transmitted infections.

Journal: Przeglad epidemiologiczny

Published: December 12, 2025

Gonorrhoea in Poland in 2023.

Journal: Przeglad epidemiologiczny

Published: December 12, 2025

Two-component systems as potential therapeutic targets in Neisseria pathogenesis.

Journal: Annals of medicine

Published: December 10, 2025

Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.

Journal: PLoS medicine

Published: December 09, 2025

Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis infections.

Journal: Antimicrobial agents and chemotherapy

Published: December 05, 2025

Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model.

Journal: Antimicrobial agents and chemotherapy

Published: December 05, 2025

The L-lactate dehydrogenase LldD contributes to oxidative stress resistance, survival from neutrophils, and host colonization in Neisseria gonorrhoeae.

Journal: bioRxiv : the preprint server for biology

Published: December 03, 2025

Prevalence of selected curable sexually transmitted infections and predetermining factors among pregnant women attending antenatal care at Gebretsadik Shawo General Hospital, Bonga, Southwest Ethiopia: a cross-sectional study.

Journal: BMJ open

Published: November 27, 2025

Antibiotic-resistance mutations in penicillin-binding protein 2 from the ceftriaxone-resistant Neisseria gonorrhoeae strain H041 strike a delicate balance between increasing resistance and maintaining transpeptidase activity.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness.

Journal: NPJ vaccines

Published: November 25, 2025

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Filters

Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae.

Zoliflodacin and gepotidacin cross-resistance in Neisseria gonorrhoeae.

Current European diagnostic and therapeutic guideline in bacterial sexually transmitted infections.

Current European diagnostic and therapeutic guideline in bacterial sexually transmitted infections.

Gonorrhoea in Poland in 2023.

Gonorrhoea in Poland in 2023.

Two-component systems as potential therapeutic targets in Neisseria pathogenesis.

Two-component systems as potential therapeutic targets in Neisseria pathogenesis.

Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.

Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.

Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis infections.

Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis infections.

Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model.

Pharmacokinetic and pharmacodynamic characterization of gepotidacin against Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh infection model.

The L-lactate dehydrogenase LldD contributes to oxidative stress resistance, survival from neutrophils, and host colonization in Neisseria gonorrhoeae.

The L-lactate dehydrogenase LldD contributes to oxidative stress resistance, survival from neutrophils, and host colonization in Neisseria gonorrhoeae.

Prevalence of selected curable sexually transmitted infections and predetermining factors among pregnant women attending antenatal care at Gebretsadik Shawo General Hospital, Bonga, Southwest Ethiopia: a cross-sectional study.

Prevalence of selected curable sexually transmitted infections and predetermining factors among pregnant women attending antenatal care at Gebretsadik Shawo General Hospital, Bonga, Southwest Ethiopia: a cross-sectional study.

Antibiotic-resistance mutations in penicillin-binding protein 2 from the ceftriaxone-resistant Neisseria gonorrhoeae strain H041 strike a delicate balance between increasing resistance and maintaining transpeptidase activity.

Antibiotic-resistance mutations in penicillin-binding protein 2 from the ceftriaxone-resistant Neisseria gonorrhoeae strain H041 strike a delicate balance between increasing resistance and maintaining transpeptidase activity.

Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness.

Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness.

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.

Structure-based engineering of a nutrient acquisition protein enhances neutralizing antibodies and protection for the development of a gonococcal vaccine.